items
With fears over manufacturing costs and future investment, here’s what firms are doing.
|
types
◈ news ×1
related tags
◈ medicine ×1
◈ investment ×1
◈ closures ×1
◈ EMA ×1
◈ statistics ×1
◈ Pfizer ×1
◈ Novartis ×1
|
|